Cabergoline - Uses, Side Effects, and More

Writer： admin Time：2023-07-20 23:01 Browse：℃

Cabgolin 0.25Mg Tablet helps in the treatment of disorders that occur as a result of very high levels of prolactin hormone in the body. This may occur because of tumour development in the pituitary gland or other reasons that are yet unknown.

Cabgolin 0.25Mg Tablet is primarily prescribed for the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas. The drug is basically a dopamine receptor agonist, which prevents the pituitary gland from producing large quantities of prolactin.

The drug may be detrimental to patients who have health complications related to high blood pressure, heart disease, disorder of the kidney or lungs. People who are allergic to any component present in Cabgolin 0.5Mg Tablet, should also consult their medical adviser before taking the medicine.

Take the drug according to the directions given in the prescription. The treatment course should not be stopped midway without the advice of your doctor. In this case the side effects of Cabgolin 0.5Mg Tablet may worsen, resulting in more complications. The drug is meant to be taken by mouth wither with food or without. In case you do miss a dose, contact your doctor and seek advice.

Confusion, gas, headache, dizzy spells, weakness, anxiety, pain in the breasts,  pimples and a runny nose are a few side effects of Cabgolin 0.5Mg Tablet that you should be aware of.

An overdose may produce nasal congestion, syncope, hallucinations, or hypotension. Measures to support blood pressure should be taken if necessary.

Patient should be instructed to notify physician if she suspects she is pregnant, becomes pregnant, or intends to become pregnant during therapy with cabergoline. A pregnancy test should be done if there is any suspicion of pregnancy and continuation of treatment should be discussed with physician.

Initial Dose: 0.25 mg twice weekly; the dose may be increased by 0.25 mg twice weekly up to a maximum of 1 mg twice weekly according to the patient's serum prolactin level. Dosage increases should not occur more rapidly than every 4 weeks.